Related Experiment Video
Updated: Jun 11, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
Cutaneous Chronic Graft-Versus-Host Disease: Clinical Manifestations, Diagnosis, Management, and Supportive Care
Connie R Shi1, Alana L Ferreira2, Manjit Kaur3
1Center for Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.
Insights
Cutaneous chronic graft-versus-host disease (cGVHD) presents varied skin symptoms after stem cell transplants. Early diagnosis and multidisciplinary care, including dermatology, are crucial for managing cGVHD and improving patient quality of life.
Area of Science:
- Dermatology
- Hematology
- Oncology
Background:
- Cutaneous chronic graft-versus-host disease (cGVHD) significantly impacts patient morbidity, mortality, and quality of life post-hematopoietic stem cell transplantation.
- Clinical presentations of cGVHD are diverse, categorized as nonsclerotic or sclerotic.
Purpose of the Study:
- To provide a comprehensive review of cutaneous cGVHD.
- To highlight unique challenges in diagnosing and managing cGVHD in skin of color.
- To outline long-term dermatologic care strategies for cGVHD survivors.
Main Methods:
- Literature review focusing on clinical presentation, diagnosis, grading, and treatment of cGVHD.
- Emphasis on underrepresented data concerning cGVHD in skin of color.
- Inclusion of long-term skin care recommendations.
Main Results:
- cGVHD diagnosis and management require careful consideration of varied clinical features.
- Skin of color presentations are often unique and may lead to diagnostic delays.
- Integrated, multidisciplinary care is essential for optimal outcomes.
Conclusions:
- Effective management of cutaneous cGVHD necessitates a thorough understanding of its diverse presentations.
- Addressing disparities in cGVHD research and care for skin of color is critical.
- Ongoing dermatologic support is vital for patients recovering from cGVHD.
Abstract:
Cutaneous chronic graft-versus-host disease (cGVHD) is associated with morbidity, mortality, and impaired quality of life after hematopoietic stem cell transplantation. The clinical features of cutaneous cGVHD are heterogeneous but can be broadly classified into nonsclerotic or sclerotic presentations. This review provides an overview of clinical presentation, diagnosis and differential diagnosis, grading, and treatment of cutaneous cGVHD. Particular attention is given to cutaneous cGVHD in skin of color, which can have unique features and is generally underrepresented in the literature leading to delays in diagnosis. Finally, an overview of long-term skin care for patients with cutaneous cGVHD is provided in order to support patients from a dermatologic perspective as they recover from cGVHD. Multidisciplinary care with frequent communication between transplant specialists and dermatologists is critical to effectively managing cutaneous cGVHD.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Cell-mediated Immune Responses
Clinical Applications of Epidermal Stem Cells
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Varicose Veins II: Diagnostic Studies and Interprofessional Care

